Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 01/21/20 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
13 | |
| 01/21/20 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
159 | |
| 01/16/20 | 8-K | Current report filing |
|
7 | |
| 01/13/20 | 8-K | Current report filing |
|
181 | |
| 01/06/20 | 8-K | Current report filing |
|
178 | |
| 12/20/19 | 8-K | Current report filing |
|
3 | |
| 12/18/19 | 8-K | Current report filing |
|
180 | |
| 12/16/19 | 8-K | Current report filing |
|
6 | |
| 12/13/19 | DEF 14A | Definitive proxy statements |
|
100 | |
| 12/11/19 | 8-K | Current report filing |
|
5 |
